![]() ![]() Finally, we suggest that mutual adaptation of BMs of platform-associated actors leads to improved diffusion of the platform offer, which also hints at the need for researchers to revisit innovation diffusion and technology adoption theories by acknowledging the importance of the BM of the offer side of technology.Ĭollaborative consumption has been changing how the people consume products in recent years. Furthermore, our study suggests that mobile payment providers need to adapt their role within the ecosystem to scale the platform, and that it will depend on their choice of scope of geographic availability. We studied how mobile payment providers engaged in innovation of their business models, and thus identified three pertaining aspects: rethinking the relationship management with retailers, creating partnerships with other actors in the payment ecosystem to complement and deliver the proposed value, and integrating and using front-end mobile technology. In this study, we take a business model (BM) perspective to understand how mobile payment platform providers go about addressing such a challenge. Engagement of patients and physicians is needed to increase the effectiveness of the partnership.The power of platform business models has grown as our economies become increasingly digital, but how companies address the challenge of platform growth to achieve a critical mass of users remains unclear. Innovations to simplify the administrative procedures in combination with performance-based incentives are needed to improve implementation. Conclusion Despite the positive attitude to the partnership, the perceived burden might outweigh the tangible benefits, posing threats to scaling up the intervention and sustainability. A number of ethical issues might undermine the equity of access to ACTs. The partnership also imposed a burden on private health providers in terms of human resources and time which entailed significant opportunity costs. Despite the good understanding of the intervention by the participating pharmacies, limited involvement of private physicians often resulted in non-standardized treatment practices. ![]() ![]() Most participants had a positive attitude towards the program, which might be associated with the perceived effectiveness of the partnership in improving access to ACTs. The proportion of malaria cases reported by community pharmacies increased from 6.9% in 2018 to 30.7% of cases. Results Only one-fourth of the total community pharmacies in Manokwari participated in the partnership, suggesting low coverage of the program. Secondary data on malaria cases and the use of ACTs reported by community pharmacies were also recorded. Audio-recorded interviews were transcribed and analyzed using thematic analysis. Study participants were program implementers, private health providers, and pharmacy clients. ![]() Qualitative methods using interviews and focus group discussions (FGDs) were employed to explore the following dimensions of acceptability: affective attitude, burden, ethicality, intervention coherence, opportunity cost, perceived effectiveness, and self-efficacy. Methods The study was conducted in Manokwari District in West Papua Province, one of the highest endemic districts in Indonesia. This paper explores the acceptability of a public-private partnership program on the provision of subsidized artemisinin-based combination therapies (ACTs) in community pharmacies from the perspectives of private health providers, patients, and program implementers. Private health providers including community pharmacies often become the first point of care for the population seeking malaria treatment however, public-private partnerships for malaria control are not widely implemented. Abstract : Background Indonesia is the second country with the highest number of malaria cases in Southeast Asia. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |